Ophthalmology · New York, NY
NPI
1780758482
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
161 E 32nd St
New York, NY, 10016
Phone (212) 979-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$646K
47,697 services
Medicare patients, 2024
1,055
Average age 75
Drug cost, 2024
$1.0M
6,376 prescriptions
Company payments, 2025
$958
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony G Curreri was code J2403 (chloroprocaine hcl ophthalmic, 3% gel, 1 mg), 41,600 times for 38 patients. In total Anthony G Curreri billed 47,697 services in 68 codes, and Medicare paid $646K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2403 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | Office | 41,600 | 38 | $0.49 | $20K |
| 92014 Ophthalmological E&M | Office | 1,327 | 808 | $103.66 | $138K |
| 92134 Computerized Ophthalmic Imaging | Office | 663 | 553 | $32.25 | $21K |
| 92250 Angiography | Office | 623 | 541 | $31.85 | $20K |
| 92136 Ultrasound - Nonspecific | Office | 536 | 344 | $23.35 | $13K |
| 92133 Computerized Ophthalmic Imaging | Office | 475 | 433 | $29.87 | $14K |
| 92202 Ophthalmological E&M | Office | 366 | 338 | $12.12 | $4,435 |
| 92012 Ophthalmological E&M | Office | 263 | 208 | $70.75 | $19K |
| 92004 Ophthalmological E&M | Office | 221 | 221 | $115.04 | $25K |
| J0178 Injection, aflibercept, 1 mg | Office | 178 | 26 | $657.56 | $117K |
| 92201 Ophthalmological E&M | Office | 157 | 148 | $20.34 | $3,193 |
| 76513 Ultrasound - Nonspecific | Office | 126 | 117 | $63.00 | $7,938 |
| 92020 Ophthalmological E&M | Office | 115 | 109 | $22.13 | $2,545 |
| 83861 Clinical Chemistry | Office | 106 | 53 | $22.03 | $2,335 |
| 67028 Intravitreal Injection | Office | 95 | 28 | $99.43 | $9,446 |
By year: 2022 $493K for 4,666 services; 2023 $527K for 5,705 services; 2024 $646K for 47,697 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 106 | 53 | $22.03 | $2,335 |
Medicare prescription drug claims, 2024
In 2024, the drug Anthony G Curreri prescribed most often to Medicare patients was Timolol Maleate, with 1,002 prescriptions and refills. In total Anthony G Curreri wrote 6,376 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Timolol Maleate Generic | 1,002 | 2,049 | 299 | $13K |
| Prednisolone Acetate Generic | 635 | 790 | 325 | $27K |
| Ketorolac Tromethamine Generic | 580 | 819 | 259 | $12K |
| Combigan Brimonidine Tartrate/Timolol | 561 | 1,107 | 186 | $255K |
| Moxifloxacin Moxifloxacin Hcl | 454 | 466 | 271 | $12K |
| Latanoprost Generic | 416 | 906 | 125 | $4,595 |
| Azelastine Hcl Generic | 344 | 437 | 140 | $5,176 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 292 | 304 | 187 | $15K |
| Brimonidine Tartrate Generic | 275 | 508 | 94 | $18K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 224 | 393 | 87 | $34K |
| Lumigan Bimatoprost | 207 | 410 | 64 | $115K |
| Bromfenac Sodium Generic | 191 | 213 | 99 | $28K |
| Alphagan P Brimonidine Tartrate | 119 | 239 | 51 | $54K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 110 | 162 | 19 | $68K |
| Restasis Cyclosporine | 99 | 187 | 37 | $109K |
Brand drugs: 2,717 claims; generic drugs: 3,659 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony G Curreri $958 ($958 in general payments such as food, travel and fees) from 12 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $301.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 14 | $301 |
| Abbvie Inc. ABBV | 8 | $193 |
| Alcon Vision LLC ALC | 4 | $99.11 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $83.31 |
| Harrow Eye, LLC | 2 | $58.88 |
| Bausch & Lomb Americas Inc. BLCO | 3 | $58.85 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $41.79 |
| Dompe US, Inc. | 1 | $26.79 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $26.08 |
| Amgen Inc. AMGN | 1 | $25.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.